Clinical Trial Update: A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 2 randomized trial evaluating AZD2014 in combination with fulvestrant in metastatic or advanced est…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AZD2014 (vistusertib)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Queen Mary University of London | Conditions: Estrogen Receptor Positive Breast Cancer | Phase 2 | Status: COMPLETED